Cours Zynex Inc. Other OTC
Actions
US98986M1036
Equipement et technologie médicale avancés
CA 2024 * | 227 M 203 M | CA 2025 * | 281 M 251 M | Capitalisation | 318 M 284 M |
---|---|---|---|---|---|
Résultat net 2024 * | 16 M 14,29 M | Résultat net 2025 * | 29 M 25,9 M | VE / CA 2024 * | 1,4 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 1,13 x |
PER 2024 * |
20,3
x | PER 2025 * |
11,2
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 37,18% |
Dernier transcript sur Zynex Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Thomas Sandgaard
CEO | Chief Executive Officer | 65 | 01/01/96 |
Daniel Moorhead
DFI | Director of Finance/CFO | 51 | 05/06/17 |
Anna Lucsok
COO | Chief Operating Officer | 38 | 01/02/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Barry Michaels
BRD | Director/Board Member | 74 | 10/01/18 |
Thomas Sandgaard
CEO | Chief Executive Officer | 65 | 01/01/96 |
Michael Cress
BRD | Director/Board Member | 66 | 10/01/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+4,64% | 212 Md | |
+8,99% | 187 Md | |
+29,83% | 155 Md | |
+35,17% | 115 Md | |
+2,28% | 65,5 Md | |
+15,06% | 52,87 Md | |
-6,47% | 45,25 Md | |
-2,14% | 39,7 Md | |
+6,88% | 37,72 Md |